Clinical Trials Browser

Phase 1/2 × Fluorescein × Clear all

NCT00847522 2017-12-20

Fluorescein for Lymphatic Mapping and Sentinel Lymph Node (SLN) Biopsy in Patients With Stage I and II Malignant Melanoma

Phase 1/2 Completed

90 enrolled 7 charts

Melanoma, Neoplasms, Skin Neoplasms

NCT01614184 2013-07-10

Fluorescein for Sentinel Lymph Node Biopsy (SLNB) in Breast Cancer

Phase 1/2 Withdrawn

Breast Neoplasms